Sleep, cardiac autonomic function, and carotid atherosclerosis in patients with cardiovascular risks: HSCAA study

Manabu Kadoya1, Hidenori Koyama1, Masafumi Kurajoh1

  • 1Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Atherosclerosis
|January 6, 2015
PubMed

Insights

Cardiac autonomic dysfunction, indicated by heart rate variability (HRV), is linked to carotid atherosclerosis, independent of sleep quality. This association is stronger in individuals with cardiovascular risk factors.

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Autonomic Nervous System Research

Background:

  • Behavioral and psychosocial factors are increasingly recognized for their impact on cardiovascular diseases.
  • Understanding the interplay between sleep, autonomic function, and atherosclerosis is crucial for cardiovascular health.

Purpose of the Study:

  • To evaluate sleep conditions, cardiac autonomic function, and carotid atherosclerosis.
  • To investigate the association between sleep, heart rate variability (HRV), and carotid atherosclerosis markers.

Main Methods:

  • Cross-sectional study of 330 patients without prior cardiovascular disease.
  • Assessed sleep efficiency, apnea-hypopnea index (AHI), HRV parameters, carotid intima-media thickness (IMT), and plaque presence/score.
  • Utilized multivariate logistic regression to identify independent associations.

Main Results:

  • Lower sleep efficiency and HRV parameters were negatively associated with IMT and plaque scores.
  • Higher AHI was positively associated with IMT and plaque scores.
  • Heart rate variability (specifically rMSSD) was independently associated with carotid plaque, irrespective of sleep conditions or traditional risk factors.

Conclusions:

  • Cardiac autonomic nervous dysfunction is independently associated with carotid atherosclerosis.
  • The link between autonomic dysfunction and atherosclerosis is more pronounced in patients with cardiovascular risk factors.
  • Sleep conditions alone did not independently predict carotid atherosclerosis in this cohort.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
785
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
833
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
806